Such products belong to the scope of the Catalog, but it should be noted that the exemption of clinical trials does not include the following 4 conditions:
- Products claimed to promote epithelialization, guide tissue regeneration, facilitate wound healing, reduce pain, stop bleeding, reduce scars, and prevent adhesions;
- Products claimed for use in internal wound, third-degree burns, infected wounds, wounds with significant necrotic tissue, patients with wound sepsis, etc.;
- Products containing active ingredients: such as pharmaceuticals/active pharmaceutical ingredients, biological products/bioactive ingredients, silver, disinfectants, etc.;
- Other new products.